Chronic dacryocystitis
Conditions
Interventions
Hemostatic patch group:S-100 absorbable hemostatic patch
Control group:none
Sponsors
Hainan Eye Hospital and Key Laboratory of Ophthalmology
Eligibility
Sex/Gender
All
Age
13 Years to 84 Years
Inclusion criteria
Inclusion criteria: (1) the patient had lacrimal discharge and purulent or viscous secretions were discharged by pressing the lacrimal sac; (2) Lacrimal duct irrigation: the needle is inserted into the lower lacrimal point to wash and flows back from the upper lacrimal point, and the flushing needle touches the bone wall, and the reflux fluid shows viscous or purulent secretions.
Exclusion criteria
Exclusion criteria: (1) history of systemic diseases (such as diabetes, hypertension, hyperthyroidism, coagulation disorder); (2) Patients under the age of 18; (3) Previous surgical history of lacrimal duct and nasal diseases; (4) trichiasis or abnormal eyelid position (such as entropion and ectropion); (5) Eyelid or nose trauma; (6) nasal diseases (such as nasal occupying, severe nasal septum deviation, polyps, sinusitis).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lacrimal passage patency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Scar formation;Granulation; | — |
Countries
China
Contacts
Public ContactBowen Ouyang
Hainan Eye Hospital and Key Laboratory of Ophthalmology
Outcome results
None listed